Brief: Argenica Therapeutics Receives Positive Feedback On Arg-007
23/08/2023 02:36
Aug 23 (Reuters) - Argenica Therapeutics Ltd AGN.AX :
* ARGENICA RECEIVES POSITIVE FEEDBACK ON ARG-007 FOLLOWING
PRE-IND
MEETING WITH FDA
Source text for Eikon: ID:nASX3fNgTm
Further company coverage: AGN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argenica Therapeutics
See all newsBrief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M